Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7351 p636
28 May 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Wholesaler knew drugs it bought were counterfeits

Genuine Cialis packaging

Counterfeiters tried to replicate the genuine Cialis packaging pictured here

At least one licensed UK pharmaceutical wholesaler knowingly bought and sold counterfeit medicines last year, according to the Medicines and Healthcare products Regulatory Agency.

Counterfeit Cialis (tadalafil) was innocently supplied to a patient by a community pharmacy last year (PJ, 28 August 2004, p277). The counterfeit product was identified after the patient complained that the tablets were crumbly when broken.
Just a week later, another wholesaler discovered that it had been sold counterfeit Reductil (sibutramine) (PJ, 11 September 2004, p335).

This week, the Medicines and Healthcare products Regulatory Agency said: “Investigations so far show that entry into the legal supply chain was achieved by one, or possibly two, licensed wholesalers (who also happen to hold parallel import licences) purchasing counterfeit Cialis and Reductil in English packaging from people who did not hold any licences to supply any medicinal products whatsoever. If proved, this will constitute an illegal transaction and not a regulatory system failure.

“ The counterfeit Cialis and Reductil then entered the legitimate UK supply chain in a wholesale transaction (not a parallel import or parallel distribution transaction) at the point when these products were sold on to other licensed wholesalers and pharmacies. Thus, the guilty party(s) appear to have knowingly purchased counterfeit products for financial gain.”

The MHRA is currently involved in a co-ordinated offshore tracking exercise, liaising with several countries across Europe. It says that the drugs have been stopped in the UK legitimate supply chain but it might still be possible to purchase them from the internet.

Back to Top


©The Pharmaceutical Journal